Evaluation of competitive funding calls: rigour, independence and traceability for public bodies
25 de September de 2026
Effectia once again collaborates with meetechSpain, a leading event for Spanish industrial innovation
5 de November de 2026Evaluation of competitive funding calls: rigour, independence and traceability for public bodies
25 de September de 2026Effectia once again collaborates with meetechSpain, a leading event for Spanish industrial innovation
5 de November de 2026Analysis, Health and healthcare transformation, Strategic planning and evaluation
· 3 de November de 2026
GRADE methodology: scientific rigour for trustworthy clinical recommendations
How can a healthcare professional make a confident decision when clinical guidelines offer different answers? The GRADE methodology provides a rigorous framework for assessing scientific evidence and turning available knowledge into reliable, transparent clinical recommendations adapted to the realities of healthcare practice.
Imagine a rheumatologist seeing a 34-year-old woman with two unexplained pregnancy losses and positive antiphospholipid antibodies. The rheumatologist must decide whether to give her anticoagulant treatment during pregnancy, which medication to use, for how long and with what level of monitoring. There is literature on the subject. There are clinical guidelines. But they do not all say the same thing, they are not all equally rigorous, and none is contextualised to the rheumatologist’s specific healthcare setting.
What gives the rheumatologist the confidence to act? The answer is not simple. But there is a methodology specifically designed to give that confidence a solid scientific foundation: GRADE (Grading of Recommendations Assessment, Development and Evaluation). Applying it correctly makes the difference between a guideline that clinicians use and one that ends up filed away.
The aim is not to use GRADE as an auxiliary tool, but as the backbone of the approach to developing Clinical Practice Guidelines (CPGs). This article explains why that commitment is not merely methodological: it is strategic.
The healthcare system needs to continue trusting its CPGs
In theory, CPGs are the bridge between scientific evidence and clinical decision-making. In practice, however, that bridge may have cracks. Until well into the 21st century, each scientific society, regulatory agency and expert group built its own evidence hierarchies: systems that were incompatible with one another, opaque in their reasoning and/or frequently affected by undeclared conflicts of interest.
The result was guidelines that contradicted other guidelines, recommendations that sounded like opinion dressed up as science, and clinicians who, when in doubt, acted out of habit or under the influence of the last conference they had attended. The problem was not a lack of evidence, but a lack of a common language for evaluating it.
GRADE was created to solve exactly that. Developed from 2000 onwards by the group led by Gordon Guyatt at McMaster University, it was formally published in The BMJ in 2004 and subsequently consolidated in a series of landmark articles in the Journal of Clinical Epidemiology (Guyatt et al., 2008; Balshem et al., 2011). The system has been adopted by more than 110 international organisations, including the WHO, the Cochrane Collaboration, NICE (United Kingdom), the European Society of Cardiology, and dozens of national health technology assessment agencies.
It is not a methodological fad, but the de facto standard of evidence-based medicine in the 21st century.
What makes GRADE different? Epistemological honesty
What distinguishes GRADE from the systems that preceded it is not its complexity (although it is a demanding system), but its honesty. GRADE clearly separates two questions that were often confused:
- How confident are we in the evidence? This is the quality of the evidence, rated at four levels (high, moderate, low, very low).
- How strongly should we recommend taking action? This is the strength of the recommendation, which can be strong or conditional.
This separation is radical because it challenges the intuition that “more evidence = a stronger recommendation”. A recommendation can be strong even when the evidence is low quality, if the risk of not acting is devastating and the adverse effects are minor. And a recommendation can be conditional even when the evidence is high quality, if patients’ values vary or the balance of benefits and risks differs according to the context (Andrews et al., 2013).
This distinction radically changes how clinical staff should read and apply a guideline; and changes even more profoundly how it should be developed.
The role of Cochrane in the GRADE ecosystem
The Cochrane Collaboration has integrated GRADE as the de facto standard in its evidence synthesis processes, through the Summary of Findings (SoF) tables that accompany each review (Higgins et al., 2023). This creates a highly valuable methodological chain of custody: from the initial search to the final recommendation, every link is auditable, reproducible and comparable.
When a CPG developed using GRADE draws on up-to-date Cochrane reviews, the result is not merely a more rigorous guideline, but one that any informed clinician can scrutinise, question and apply with judgement. That is what distinguishes a tool from a reference.